DailyIQ
Last updated1 minute ago

UHS·Universal Health Services, Inc.

$186.67
+7.66 (+4.28%)
High
$186.90
Open
$180.08
Market Cap
10.48B
52W High
$246.33
Low
$179.96
P. Close
$186.67
P/E
6.87
52W Low
$138.06
Fwd P/E
7.57
DailyIQ Est.
$195.67
Inst. Ownership
37.2%
Short Interest
4.37%
Days to Cover
2.8
Div. Yield
0.45%
Next Ex-Div
~Dec 1
Technical Score (1D)
64
BULLISH
News Sentiment
46
MIXED
UHS is setting up for a potential resolution: BUY at 64 with firm momentum on the 1D chart. Sentiment at 46 is diverging from the bullish bias, so confirmation still matters. $184.46 is the line bulls need to clear; $170.28 defines the risk if the attempt stalls. Momentum-driven buyers tend to show up only after $184.46 actually breaks, which means the setup can look identical for days before anything changes on the tape. That's the nature of breakout-watch conditions: the BUY read and firm momentum describe the pressure building, not the timing of when it releases.
LOW TARGET
$166 -11.1%
3 analysts
MEAN TARGET
$195 +4.4%
14 analysts
HIGH TARGET
$290 +55.4%
10 analysts
PRICE RANGE
$166.00 - $290.00
SB / B / H / S / SS
3/6/16/1/1
DAILYIQ EST.
$195.67 (+4.8%)
Sector
Healthcare
Industry
Medical Care Facilities
Exchange
NYQ
Country
United States
Website
Symbol
UHS
Description
Universal Health Services (UHS) is a healthcare provider focused on delivering a comprehensive range of services through its network of facilities. The company operates in two primary segments: acute care hospitals and behavioral health care services. UHS's acute care hospitals offer a wide array of medical specialties, including surgery, internal medicine, and emergency services, while its behavioral health facilities provide specialized care. Beyond direct patient care, UHS also supports its operations with commercial health insurance offerings and a suite of management services. Founded in 1978, UHS is headquartered in King of Prussia, Pennsylvania, and has established itself as a key player in the healthcare industry.
Bought (1Y)
0 shares
$0
Sold (1Y)
0 shares
$0
MILLER ALAN BExecutive Chairman
J25,495 shares2026-05-27
MILLER ALAN BExecutive Chairman
J50,990 shares2026-05-27
MILLER ALAN BExecutive Chairman
J14,163 shares2026-05-27
MILLER ALAN BExecutive Chairman
J9,418 shares2026-05-27
MILLER ALAN BExecutive Chairman
J13,963 shares2026-05-27
71/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Net Margin
8.6%
Revenue CAGR
7.6%
Current Ratio
1.05x
Debt / Equity
0.65x
Return on Equity
20.5%
Earnings Summary
Universal Health Services (UHS) operates as a comprehensive healthcare provider, delivering acute care through its hospital network and specialized behavioral health services, while also offering commercial health insurance and management solutions. The company’s dual‑segment model positions it within the broader medical care facilities sector, where integrated care and cost efficiency are key competitive drivers. In the most recent quarters, UHS demonstrated robust earnings momentum: Q4 2025 EPS of $5.88 slightly missed the $5.9595 estimate, yet revenue of $4.4861 B fell short of the $4.5471 B forecast, reflecting a modest revenue contraction. In contrast, Q1 2026 EPS of $5.62 beat the $5.89236 estimate, and revenue of $4.4952 B matched the $4.5768 B estimate, indicating a rebound in profitability. The company’s EPS trend has accelerated from $4.92 in Q1 2025 to $5.69 in Q3 2025, while revenue grew from $4.0997 B to $4.4952 B over the same period, underscoring consistent earnings growth despite occasional revenue dips. Historically, UHS has maintained a positive YoY revenue trajectory, with EPS frequently beating analyst expectations in the last four quarters, though revenue has occasionally lagged forecasts, suggesting a pattern of earnings resilience amid revenue volatility. Recent news highlights the acquisition of Talkspace in early October 2026, a strategic move to expand digital behavioral health offerings and potentially diversify revenue streams; this development may influence future earnings dynamics by adding a scalable virtual therapy layer to UHS’s portfolio. Key will be the company’s ability to translate the acquisition into measurable financial performance and to maintain EPS growth while managing revenue fluctuations.

EPS

EstBeatMiss
$4.79$5.14$5.48$5.82$6.17Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$5.16 - -
Q2'26$6.01$5.98-0.4%
Q1'26$5.89$5.62-4.6%
Q4'25$5.96$5.88-1.3%
Q3'25$4.95$5.69+14.9%
Q2'25$4.96$5.35+8.0%

Revenue

EstBeatMiss
$4.2B$4.4B$4.5B$4.7B$4.8BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$4.8B - -
Q2'26$4.6B$4.6B+0.3%
Q1'26$4.6B$4.5B-1.8%
Q4'25$4.5B$4.5B-1.3%
Q3'25 - $4.5B -
Q2'25 - $4.3B -

Market Data

UHS Stock Snapshot

NEUTRAL64/100
$186.67+$7.66 (4.3%)
Market cap
10.48B
P/E ratio
6.9
Day range
$179.96 – $186.90
News sentiment
46/100 · Neutral
Analyst target
$194.94 (+4.4%)
Consensus
Hold · 27 analysts
52-week range+35.2% off low · -24.2% from high
$138.06$246.33
Price $186.67 DailyIQ Est. $195.67

The technical read on UHS is balanced, which usually means the market is waiting on a catalyst. In Healthcare, names this size usually take direction from sector flows before company-level news.

Reverse DCF

What growth is priced into UHS?

CHEAP

At today's price, Universal Health Services, Inc. needs to grow free cash flow about -4.7% a year for the next 10 years to justify its valuation at a 6.67% cost of capital. Over its actual history it has compounded free cash flow at 5.0% a year, so the market is asking for 9.7 percentage points below its own delivered rate. On that basis UHS looks priced below what its own growth record supports.

Implied FCF growth
-4.7%
Historical FCF CAGR
5.0%
Growth gap
-9.7 pts
Verdict
CHEAP
Discount rate (WACC)
6.67%
Beta
0.66

Behaviour On Record

What UHS's own history says about today's numbers

Realized volatility (21d)
21.4% 31st pct
Below its peak
-26.7%
vs 200-day average
-0.1%
Up days (1y)
49%

Universal Health Services, Inc. is currently running 21.4% annualised volatility over the last 21 sessions. Measured against UHS's own 13 years of daily returns rather than a market-wide average, that is the 31st percentile — on the quiet side for this stock, against a typical reading of 25.1%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

UHS is trading -26.7% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -24.0%, and the deepest was -54.2% in 2020. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits -0.1% from its 200-day moving average. Against every other day in its history, that gap ranks at the 42nd percentile — close to the gap it normally carries. Over the past year UHS closed higher on 49% of sessions, and it is currently 4 sessions into a rising streak.

On October specifically: over 13 years of records, UHS finished the month higher 5 of 13 times, with a median return of -0.3% and an average of -0.5%. Its strongest month historically has been July at +5.1% on average, its weakest September at -2.0%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: UHS has opened more than 2% away from the prior close in 119 of 3,267 sessions (3.6% of the time), with the largest gaps running +7.2% and -11.6%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, UHS moved an average of 7.8% in the session after earnings, closing higher 1 of those 3 times, with a median move of -4.4% and a largest of -10.7%.

All figures computed from 3,268 daily closes between 2013-10-15 and 2026-10-13, split-adjusted, recomputed daily. Percentiles are against UHS's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of UHS's sector?

Universal Health Services, Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).

Sector rank
#2 of 12
Sector state
Leading
Sector rotation score
91

Options Market

What is the options market pricing for UHS?

CallsPuts

For Universal Health Services, Inc.'s nearest expiry (2026-10-16, 2 days out), open interest is roughly balanced between puts and calls (put/call ratio of 0.94), with at-the-money implied volatility around 47.6%. The options market is pricing roughly a ±4.1% move by that expiry — a range of about $177.51–$192.85.

Put/call ratio (2026-10-16)
0.94
ATM implied volatility
47.6%
Total open interest
1,637
Expected move by 2026-10-16
±4.1% ($177.51–$192.85)

Analyst Rating Changes

Are analysts turning bullish or bearish on UHS?

Leerink Partners most recently reiterated its rating on Universal Health Services, Inc. to Outperform on Sep 18, 2026 with a price target of $205 (from $198). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Leerink Partners — Outperform
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Sep 18, 2026Leerink PartnersMaintainedOutperform$198 → $205
Aug 20, 2026RBC CapitalReiteratedSector Perform$183
Aug 3, 2026RBC CapitalMaintainedSector Perform$190 → $183
Jul 30, 2026Goldman SachsMaintainedNeutral$242 → $190
Jul 29, 2026Morgan StanleyMaintainedEqual-Weight$212 → $191
Jul 29, 2026GuggenheimMaintainedBuy$195 → $189
Jul 29, 2026Cantor FitzgeraldReiteratedNeutral$194
Jul 29, 2026BairdMaintainedNeutral$204 → $166
Jul 28, 2026Cantor FitzgeraldReiteratedNeutral$194
Jul 28, 2026BarclaysMaintainedEqual-Weight$179 → $168
Jul 20, 2026GuggenheimMaintainedBuy$211 → $195
Jul 13, 2026Wells FargoMaintainedEqual-Weight$165 → $166

Peers & ETF holders

UHS peers & ETF holders

News Sentiment Analysis

Sentiment gathered from recent headlines

46/100
Strong NegativeNeutralStrong Positive
MIXED

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Analysts reviewed the upcoming Universal Health Services earnings release, noting that guidance was expected to align with prior forecasts. The company was projected to report revenue growth driven by increased inpatient admissions and expanded outpatient services. Management emphasized cost control measures and a focus on operational efficiency. No significant catalysts or surprises were identified ahead of the earnings announcement.
What did this article say?
Universal Health Services, Inc. (UHS) announced on October 9, 2026 that its third‑quarter earnings release would now occur after market close on October 27, 2026, with the investor conference call scheduled for 8:00 a.m. Eastern on October 28, 2026. The change was made to prevent overlap with other healthcare company calls. The adjustment is a procedural update and does not indicate any change in financial performance or outlook.
What did this article say?
Universal Health Services completed the acquisition of Talkspace, adding a digital therapy platform to its portfolio. The deal is expected to diversify revenue streams and enhance long‑term growth prospects. Analysts view the transaction as a strategic move to capture the expanding behavioral health market. The acquisition may justify a higher valuation if the new platform delivers projected synergies. Overall, the deal signals a positive shift in UHS’s growth trajectory.
What did this article say?
Universal Health Services CEO Mark Miller announced the company’s acquisition of Talkspace, a digital therapy platform, as part of a strategy to extend behavioral health services beyond its traditional inpatient focus. The deal aims to create a seamless continuum of care that integrates inpatient, outpatient, and virtual treatment options for patients at different stages of recovery. By combining Talkspace’s technology with UHS’s existing facilities, the company intends to enhance patient access and improve treatment outcomes across its network.
What did this article say?
Stephens increased its price target for Universal Health Services to $180 from $170 while keeping an equalweight rating. The adjustment reflects a modest confidence boost for the company, suggesting expectations of continued solid performance. The new target aligns with the broader consensus of an average rating of overweight and a mean price target of $193.88. This move indicates analysts see potential upside but remain cautious about significant upside catalysts.
What did this article say?
Universal Health Services, Inc. (NYSE: UHS) disclosed that its third‑quarter 2026 earnings will be released after the market close on October 26, 2026, followed by a conference call on October 27. The company outlined access options for the webcast and telephone participation. The update is a routine schedule announcement with no effect on financial forecasts.
What did this article say?
On September 30, 2026, a $360 put on UHS ranked among the highest implied‑volatility contracts, highlighting heightened uncertainty. The stock’s share price had slipped 0.84% over one day and 3.93% over seven days, while its 90‑day return remained positive at 10.06%. Long‑term shareholders still enjoyed a 42.29% total return over three years, suggesting that the recent volatility spike reflects a shift in growth expectations rather than a fundamental collapse. The event underscores a short‑term headwind for UHS, with potential implications for investor sentiment and option pricing.
What did this article say?
Investors noted that the Oct 16, 2026 $360 put on UHS exhibited unusually high implied volatility, indicating market expectations of a significant price swing. The spike in options pricing suggests that traders anticipate a forthcoming event that could trigger a rally or a sharp decline. No concrete catalyst has been identified, and the company’s fundamentals remain unchanged, leaving the direction of the move uncertain. The heightened volatility serves as a cautionary signal rather than a definitive forecast of upside or downside.
What did this article say?
On Sep 24, the article highlighted Universal Health Services (UHS) as a large-cap provider with acute-care and behavioral-health segments. It noted that UHS’s extensive network and scale afford operational efficiencies and broad payer relationships. Despite these strengths, the piece pointed out a roller‑coaster performance trend, suggesting that UHS has been underperforming relative to the broader healthcare sector. The commentary emphasized the company’s competitive position while acknowledging volatility in its recent results.
What did this article say?
Leerink Partners lifted its price target for Universal Health Services from $198 to $205, reflecting a more optimistic view of the company’s earnings potential. The upgrade comes amid a broader trend of analysts revising UHS targets upward, with several banks raising their objectives and maintaining buy or outperform ratings. The move suggests confidence in UHS’s ability to generate higher cash flows and improve profitability, though it does not indicate a transformative shift.

Technical Analysis

Real-time indicators across multiple timeframes

64
BULLISH
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $3.66B combined position · 14 adding, 11 trimming, 0 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
Vanguard Group Inc▼ Sell6,486,54211.08%$1.41B2026-01-29
BlackRock, Inc.▼ Sell4,059,8266.93%$603.66M2026-08-07
Geode Capital Management, LLC▲ Buy1,974,0653.37%$293.15M2026-08-12
Invesco Ltd.▲ Buy1,951,1473.33%$290.12M2026-08-14
FMR LLC (Fidelity)▲ Buy1,416,7552.42%$210.66M2026-08-13
Norges Bank▼ Sell888,4991.52%$132.11M2026-08-12
Morgan Stanley▲ Buy749,7541.28%$111.48M2026-08-13
Goldman Sachs Group Inc▼ Sell601,9531.03%$89.50M2026-08-14
AQR Capital Management LLC▼ Sell523,2100.89%$76.89M2026-08-14
Northern Trust Corp▼ Sell450,8210.77%$67.03M2026-08-13
Millennium Management LLC▼ Sell417,3690.71%$62.06M2026-08-14
Citadel Advisors LLC▲ Buy308,1470.53%$45.82M2026-09-02
Bridgewater Associates, LP▲ Buy228,1210.39%$33.92M2026-08-14
Moore Capital Management, LP▲ Buy222,4220.38%$33.07M2026-08-14
JPMorgan Chase & Co▼ Sell198,9750.34%$29.60M2026-08-12
Bank of America Corp▼ Sell184,0070.31%$27.36M2026-08-14
D. E. Shaw & Co., Inc.▲ Buy145,2500.25%$21.60M2026-08-14
Squarepoint Ops LLC▲ Buy143,0950.24%$21.28M2026-08-14
Susquehanna International Group, LLP▲ Buy125,8080.21%$18.71M2026-08-14
Citigroup Inc▲ Buy121,2090.21%$18.02M2026-08-03
Gotham Asset Management, LLC▼ Sell99,9270.17%$14.86M2026-08-14
Wells Fargo & Company▼ Sell89,1930.15%$13.26M2026-08-14
AllianceBernstein L.P.▲ Buy73,7750.13%$13.20M2026-08-14
Prudential Financial Inc▲ Buy81,6390.14%$12.14M2026-08-12
Man Group plc▲ Buy66,9950.11%$9.96M2026-08-14
Q2 2026 flow:1.38M sh bought ($206.17M)1.73M sh sold ($257.29M)net -347.2K sh (−$51.12M)
Congressional Trading Activity
3 disclosed trades · ~$24.0K est. traded value · 2 buys, 1 sells
MemberChamberStateTypeAmountTradedFiled
Alan ArmstrongSenateOK▲ Buy$1K - $15K2026-03-272026-07-21
Julia LetlowHouseLA05▲ Buy$1K - $15K2025-10-232026-01-13
Julia LetlowHouseLA05▼ Sell$1K - $15K2025-01-242026-01-13